Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PE

Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy Immunohistochemistry In Situ Hybridization), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), By End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Cancer diagnostics are procedures used for the identification of cancer with or without incision in the body. Detection and treatment of cancer at early stages are important for long-term survival. Non-invasive cancer detection method is found to be an increasing choice of interest, owing to its painless or minimal pain method of diagnostic coupled with more accurate results. Molecular based diagnostic methods are expected to increase during the forecast period due to launches of new biomarker based detection methods. Moreover, factors like increasing incidence of cancer, increasing cancer screening rate, government initiatives, and emerging technologies such as next generation sequencing are expected to drive the market during the forecast period.

Restraints of the Global Cancer Diagnostics Market

Major factors hampering the growth of the cancer diagnostics market during the forecast period constitutes of high costs, and inadequate reimbursement.

Key features of the study:

This report provides in-depth analysis of the global cancer diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global cancer diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Aurora Imaging Technologies, Inc., and Quest Diagnostics

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Cancer Diagnostics Market, By Test Type:

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

Global Cancer Diagnostics Market, By Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

Global Cancer Diagnostics Market, By End User:

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

Global Cancer Diagnostics Market, By Geography:

North America

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country:

U.S.

Canada

Europe

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country:

GCC

Israel

Rest of Middle East

Africa

By Test Type

Tumor Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA-19 Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

By Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancers

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

By End User

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Abbott Laboratories *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

F. Hoffmann-La Roche Ltd.

Thermo Fisher Scientific Inc.

Siemens AG

Bio Rad Laboratories Inc.

GE Healthcare

Illumina, Inc.

Koninklijke Philips N.V.

Toshiba Medical Systems Corporation

Agilent Technologies, Inc.

Aurora Imaging Technologies, Inc.

Quest Diagnostics

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Test Type
Market Snippet, By Cancer Type
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Cancer Diagnostics Market, By Test Type, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Tumor Biomarkers Tests
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
PSA Tests
CTC Tests
AFP Tests
CA-19 Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Imaging
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Ultrasound
Mammography
MRI Scan
PET Scan
CT Scan
SPECT & Others
Biopsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Needle Biopsy
Endoscopic Biopsy
Bone Marrow Biopsy
Others
Liquid Biopsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
Immunohistochemistry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
In Situ Hybridization
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Segment Trends
5. Global Cancer Diagnostics Market, By Cancer Type, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Melanoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Blood Cancers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Ovarian Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Stomach Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Liver Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Cancer Diagnostics Market, By End User, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
Hospital Associated Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Independent Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Diagnostic Imaging Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Cancer Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
7. Global Cancer Diagnostics Market, By Regions, 2019 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2017–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Siemens AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bio Rad Laboratories Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GE Healthcare
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Illumina, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Koninklijke Philips N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Toshiba Medical Systems Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Agilent Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurora Imaging Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Quest Diagnostics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 38 market data tables and 56 figures on “Cancer Diagnostics Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook